These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3656097)

  • 1. Hypolipidemic activity of trimethylamine-carbomethoxyborane and related derivatives in rodents.
    Hall IH; Spielvogel BF; Sood A; Ahmed F; Jafri S
    J Pharm Sci; 1987 May; 76(5):359-65. PubMed ID: 3656097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of trimethylamine-carbomethoxyborane on growth traits and lipid metabolism in lines of mice selected for high and low fat content.
    Eisen EJ; Jones EE; Rajendran KG; Hall IH
    Growth Dev Aging; 1996; 60(1):7-20. PubMed ID: 8718926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hypolipidemic activity of heterocyclic amine boranes in rodents.
    Hall IH; Sood A; Spielvogel BF
    Biomed Pharmacother; 1991; 45(8):333-41. PubMed ID: 1773021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and hypolipidemic activity of amine-carboxyboranes, and their amides and esters in rodents.
    Sood A; Sood CK; Spielvogel BF; Hall IH; Wong OT; Mittakanti M; Morse K
    Arch Pharm (Weinheim); 1991 Jul; 324(7):423-32. PubMed ID: 1763952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of isoxazolidine or triazolidine on rat serum lipids in vivo and LDL and HDL binding and degradation in human and rodent cultured cells in vitro.
    Hall IH; Wong OT; Simlot R; Izydore RA
    Res Commun Chem Pathol Pharmacol; 1992 Sep; 77(3):327-46. PubMed ID: 1333628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and pharmacological activities of amine-boranes.
    Burnham BS
    Curr Med Chem; 2005; 12(17):1995-2010. PubMed ID: 16101500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypolipidemic activity of the surfactants aminimides, and their effects on lipid metabolism of rodents.
    Hall IH; Kabara JJ; Matthews TG
    Lipids; 1985 Oct; 20(10):685-92. PubMed ID: 2865666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypolipidemic, anti-obesity, anti-inflammatory, anti-osteoporotic, and anti-neoplastic properties of amine carboxyboranes.
    Hall IH; Chen SY; Rajendran KG; Sood A; Spielvogel BF; Shih J
    Environ Health Perspect; 1994 Nov; 102 Suppl 7(Suppl 7):21-30. PubMed ID: 7889876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypolipidemic activity of N,N-dimethyl-n-octadecylamine borane in rodents.
    Hall IH; Griffin TS; Docks EL; Brotherton RJ; Futch G
    J Pharm Sci; 1986 Jul; 75(7):706-10. PubMed ID: 3761173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypolipidemic activity of o-(N-phthalimido)acetophenone in Sprague Dawley rats.
    Hall IH; Reynolds DJ; Wong OT; Oswald CB; Murthy AR
    Pharm Res; 1987 Dec; 4(6):472-9. PubMed ID: 3508559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypolipidemic activity of 6-amino-2-mercapto-5-methyl-pyrimidine-4-carboxylic acid and related derivatives in rodents.
    Hall IH; Cocolas GH; Murthy AR; Rhyne KA; Knowles M
    J Pharm Sci; 1985 Jul; 74(7):759-64. PubMed ID: 4032250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypolipidaemic activity in rodents of boron analogs of phosphonoacetates and cyanoborane adducts of dialkyl aminomethylphosphonates.
    Hall IH; Wong OT; Sood A; Sood CK; Spielvogel BF; Shrewsbury RP; Morse KW
    Pharmacol Res; 1992 Apr; 25(3):259-70. PubMed ID: 1518770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hypolipidemic activity of 1-N-3-methylphthalimido-butan-3-semicarbazone in rodents.
    Wong OT; Hall IH; Chapman JM
    Pharm Res; 1989 Mar; 6(3):230-4. PubMed ID: 2726679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypolipidemic activity of 6-substituted 6,7-dihydro-5H-dibenz[c,e]azepine and the effects of 6,7-dihydro-5H-dibenz[c,e]azepine on lipid metabolism of rodents.
    Hall IH; Murthy AR; Wyrick SD
    J Pharm Sci; 1986 Jun; 75(6):622-6. PubMed ID: 3735111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypolipidemic activity of 3-N-(1',8'-Naphthalimido)propionic acid in rodents.
    Hall IH; Chapman JM; Voorstad PJ; Cocolas GH
    J Pharm Sci; 1984 Jul; 73(7):956-61. PubMed ID: 6547980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypolipidemic activity of 3- and 4-phenyl-piperidine-2,6-diones and selected N-substituted derivatives.
    Murthy AR; Maguire JH; Alphin RS; Day PA; Hall IH
    Lipids; 1986 Oct; 21(10):617-22. PubMed ID: 3796228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypolipidemic activity of 18beta-glycyrrhetinic acid on streptozotocin-induced diabetic rats.
    Kalaiarasi P; Kaviarasan K; Pugalendi KV
    Eur J Pharmacol; 2009 Jun; 612(1-3):93-7. PubMed ID: 19361497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypolipidemic activity of 6-alkoxycarbonyl-3-aryl-1,3,5- triazabicyclo[3.1.0]hexane-2,4-diones and 2-alkoxycarbonyl-5-aryl-1,3,5-triazine-4,6(1H,5H)-diones in rodents.
    Izydore RA; Wong OT; Hall IH
    Lipids; 1993 Mar; 28(3):223-9. PubMed ID: 8464353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and hypolipidemic activity of 3-imino-1-oxoisoindolines in rodents.
    Murthy AR; Wong OT; Reynolds DJ; Hall IH
    Pharm Res; 1987 Feb; 4(1):21-7. PubMed ID: 3508524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale for use of non-high-density lipoprotein cholesterol rather than low-density lipoprotein cholesterol as a tool for lipoprotein cholesterol screening and assessment of risk and therapy.
    Frost PH; Havel RJ
    Am J Cardiol; 1998 Feb; 81(4A):26B-31B. PubMed ID: 9526810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.